Tilray Medical said it has now received approval for the first medical cannabis extract, Tilray Oral Solution THC 5 CBD 20, in Portugal, marking a milestone in medical cannabis availability and patient care within the country.
This approval, confirmed on March 11, 2024, underscores Tilray's commitment to expanding safe and regulated access to medical cannabis for patients in need. The newly approved medical cannabis extract is set to launch in late spring, offering new therapeutic options for patients across Portugal with specified medical conditions. The approved extract is indicated for use in several critical areas of patient care.
Tilray Medical offers a portfolio of EU-GMP certified medicinal cannabis products and has operations extending over 20 countries.
